TY - JOUR AU - Ferro, J. M. AU - Canhão, P. AU - Stam, J. AU - Bousser, M. -. G. PY - 2004 DA - 2004// TI - Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) JO - Stroke. VL - 35 UR - https://doi.org/10.1161/01.STR.0000117571.76197.26 DO - 10.1161/01.STR.0000117571.76197.26 ID - Ferro2004 ER - TY - JOUR AU - Einhäupl, K. M. AU - Villringer, A. AU - Mehraein, S. AU - Garner, C. AU - Pellkofer, M. AU - Haberl, R. L. PY - 1991 DA - 1991// TI - Heparin treatment in sinus venous thrombosis JO - Lancet. VL - 338 UR - https://doi.org/10.1016/0140-6736(91)90607-Q DO - 10.1016/0140-6736(91)90607-Q ID - Einhäupl1991 ER - TY - JOUR AU - Coutinho, J. AU - Bruijn, S. F. AU - Deveber, G. AU - Stam, J. PY - 2011 DA - 2011// TI - Anticoagulation for cerebral venous sinus thrombosis JO - Cochrane Database Syst Rev VL - 10 ID - Coutinho2011 ER - TY - JOUR AU - Saposnik, G. AU - Barinagarrementeria, F. AU - Brown, R. D. AU - Bushnell, C. D. AU - Cucchiara, B. AU - Cushman, M. PY - 2011 DA - 2011// TI - Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association JO - Stroke. VL - 42 UR - https://doi.org/10.1161/STR.0b013e31820a8364 DO - 10.1161/STR.0b013e31820a8364 ID - Saposnik2011 ER - TY - JOUR AU - Ferro, J. M. AU - Bousser, M. -. G. AU - Canhão, P. AU - Coutinho, J. M. AU - Crassard, I. AU - Dentali, F. PY - 2017 DA - 2017// TI - European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology JO - Eur J Neurol VL - 24 UR - https://doi.org/10.1111/ene.13381 DO - 10.1111/ene.13381 ID - Ferro2017 ER - TY - JOUR AU - Schulman, S. AU - Kearon, C. AU - Kakkar, A. AU - Mismetti, P. AU - Schellong, S. AU - Eriksson, H. PY - 2009 DA - 2009// TI - Dabigatran versus warfarin in the treatment of acute venous thromboembolism JO - N Engl J Med. VL - 361 UR - https://doi.org/10.1056/NEJMoa0906598 DO - 10.1056/NEJMoa0906598 ID - Schulman2009 ER - TY - JOUR AU - Mekaj, Y. H. AU - Mekaj, A. Y. AU - Duci, S. B. AU - Miftari, E. I. PY - 2015 DA - 2015// TI - New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events JO - Ther Clin Risk Manag VL - 11 UR - https://doi.org/10.2147/TCRM.S84210 DO - 10.2147/TCRM.S84210 ID - Mekaj2015 ER - TY - JOUR AU - Moher, D. AU - Shamseer, L. AU - Clarke, M. AU - Ghersi, D. AU - Liberati, A. AU - Petticrew, M. PY - 2015 DA - 2015// TI - Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement JO - Syst Rev VL - 4 UR - https://doi.org/10.1186/2046-4053-4-1 DO - 10.1186/2046-4053-4-1 ID - Moher2015 ER - TY - JOUR AU - Liberati, A. AU - Altman, D. G. AU - Tetzlaff, J. AU - Mulrow, C. AU - Gøtzsche, P. C. AU - Ioannidis, J. P. A. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b2700 DO - 10.1136/bmj.b2700 ID - Liberati2009 ER - TY - STD TI - Bose G, Graveline J, Dowlatshahi D. Systematic review of direct oral anticoagulants in treatment of cerebral venous thrombosis. PROSPERO 2017 CRD42017078398. Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017078398. UR - http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017078398 ID - ref10 ER - TY - JOUR AU - Sterne, J. A. AU - Hernán, M. A. AU - Reeves, B. C. AU - Savović, J. AU - Berkman, N. D. AU - Viswanathan, M. PY - 2016 DA - 2016// TI - ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JO - BMJ VL - 355 UR - https://doi.org/10.1136/bmj.i4919 DO - 10.1136/bmj.i4919 ID - Sterne2016 ER - TY - STD TI - Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Joanna Briggs Institute Reviewer’s Manual. Joanna Briggs Inst. 2017; Chapter 7. ID - ref12 ER - TY - JOUR AU - Geisbüsch, C. AU - Richter, D. AU - Herweh, C. AU - Ringleb, P. A. AU - Nagel, S. PY - 2014 DA - 2014// TI - Novel factor Xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients JO - Stroke. VL - 45 UR - https://doi.org/10.1161/STROKEAHA.114.006167 DO - 10.1161/STROKEAHA.114.006167 ID - Geisbüsch2014 ER - TY - JOUR AU - Mendonça, M. D. AU - Barbosa, R. AU - Cruz-e-Silva, V. AU - Calado, S. AU - Viana-Baptista, M. PY - 2015 DA - 2015// TI - Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients JO - Int J Stroke VL - 10 UR - https://doi.org/10.1111/ijs.12462 DO - 10.1111/ijs.12462 ID - Mendonça2015 ER - TY - STD TI - Thalia Field U of BC. Study of Rivaroxaban for CeREbral Venous Thrombosis (SECRET). ClinicalTrials.gov Identifier: NCT03178864. ID - ref15 ER - TY - STD TI - Islamabad FU. Comparison of the efficacy of rivroxaban to Coumadin (warfarin) in cerebral venous thrombosis (CVT). ClinicalTrials.gov Identifier: NCT03191305. ID - ref16 ER - TY - STD TI - Ji Xunming CMU. The efficacy and safety of dabigatran etexilate for the treatment of cerebral venous thrombosis. ClinicalTrials.gov Identifier: NCT03217448. ID - ref17 ER - TY - JOUR AU - Ferro, J. M. AU - Dentali, F. AU - Coutinho, J. M. AU - Kobayashi, A. AU - Caria, J. AU - Desch, M. PY - 2018 DA - 2018// TI - Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis JO - Int J Stroke VL - 0 ID - Ferro2018 ER - TY - STD TI - Ingelheim B. A clinical trial comparing efficacy and safety of dabigatran etexilate with warfarin in patients with cerebral venous and dural sinus thrombosis (RE-SPECT CVT) (ClinicalTrials.gov Identifier: NCT02913326). ID - ref19 ER -